New hope for immunocompromised patients with severe parainfluenza
Disease control
Recruiting now
This study tests an experimental drug called DAS181 in people with weakened immune systems who have a serious lung infection caused by parainfluenza virus. The goal is to see if the drug helps them breathe without extra oxygen and reduces the risk of death. About 274 participants…
Phase: PHASE3 • Sponsor: Ansun Biopharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC